Company Description
Carmell Corporation operates as a bio-aesthetics company.
The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks.
The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Its microemulsion formulations do not utilize mineral or vegetable oils and are designed to be non-comedogenic.
In addition, the company is also developing a line of men's products and a line of topical haircare products.
It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics for all fields of use.
The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023.
Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
| Country | United States |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Rajiv Sarman Shukla |
Contact Details
Address: 1177 Avenue Of The Americas, 5th Floor New York, New York 10036 United States | |
| Phone | 646-494-3296 |
| Website | carmellrx.com |
Stock Details
| Ticker Symbol | CTCX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001842939 |
| ISIN Number | US1429221039 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Rajiv Sarman Shukla | Executive Chairman and Chief Executive Officer |
| Dr. Phil Campbell Ph.D. | Founder and Chief Scientific Officer |
| Dr. Lee Weiss Ph.D. | Founder |
| Dr. James Burgess M.D. | Founder |
| Bryan J. Cassaday | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Apr 4, 2024 | 8-K | Current Report |
| Apr 1, 2024 | 8-K | Current Report |
| Apr 1, 2024 | 10-K | Annual Report |
| Mar 26, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |